6 March 2020
In the project, an international consortium comprising researchers from Denmark, Sweden, Germany and The Netherlands, together with a number of companies, will probe new technologies to analyse monosaccharide sequences in heparin/heparan sulfate and apply defined oligosaccharides in the field of regenerative medicine.
A grant of 592 kEuro has been awarded to Toin van Kuppevelt and Willeke Daamen, Dept. of Biochemistry, theme Reconstructive and regenerative medicine, for a Horizon 2020 FET-OPEN project entitled “Heparin and heparan sulphate: from sequence determination to therapeutic strategies for Parkinson’s disease”.
In the project, an international consortium comprising researchers from Denmark, Sweden, Germany and The Netherlands, together with a number of companies, will probe new technologies to analyse monosaccharide sequences in heparin/heparan sulfate and apply defined oligosaccharides in the field of regenerative medicine.